ESCRS - FP39 - VISUAL OUTCOMES OF BILATERAL IMPLANTATION OF A NEW NON-DIFFRACTIVE EXTENDED VISION INTRAOCULAR LENS (IOL) (ACRYSOF® IQ VIVITY)

VISUAL OUTCOMES OF BILATERAL IMPLANTATION OF A NEW NON-DIFFRACTIVE EXTENDED VISION INTRAOCULAR LENS (IOL) (ACRYSOF® IQ VIVITY)

Published 2022 - 26th ESCRS Winter Meeting

Reference: FP39 | Type: Abstracts | DOI: 10.82333/3ptp-zm53

Authors: Joaquim Neto Murta* 1 , Telmo Cortinhal 1 , Celso Costa 2 , Maria Silva 1 , Maria Joao Quadrado 1 , Miguel Raimundo 1

1Ophthalmology Department Ophthalmology,Ophthalmology Department Ophthalmology,COIMBRA,Portugal, 2Ophthalmology Department Ophthalmology, Ophthalmology Department Ophthalmology,COIMBRA,Portugal

Purpose

To reports refractive and visual outcomes, spectacle independence, patient -reported outcomes following bilateral sequential bilateral implantation of a non-diffractive extended vision IOL.

Setting

1- Department of Ophthalmology, Coimbra Hospital and University Center (CHUC), Coimbra, Portugal

2- Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal

3 – Faculty of Medicine, University of Coimbra (FMUC), Coimbra, Portugal

4 – Unidade de Oftalmologia de Coimbra (UOC), Coimbra, Portugal

Methods

Patients were bilaterally implanted with a non-diffractive extended vision IOL (Alcon Vivity), targeting minimonovision (nearest power for emmetropia in the dominant eye, between -0.25D and -0.50D in the nondominant eye). Post-operative outcome measures included spherical equivalent (SE) determined by subjective refraction, binocular uncorrected distance visual acuity (UDVA), binocular uncorrected intermediate visual acuity – 66 cm (UIVA) and binocular uncorrected near visual acuity -40 cm (UNVA) in photopic conditions, spectacle independence, photic phenomena and Catquest-9SF questionnaires.

Results

148 eyes of 74 patients were included, age 64.58±8.41 years old, 66.22% female (49/74). A toric IOL was implanted in 18.24% of eyes (27/148). Binocular UDVA, UIVA and UNVA was 0.02±0.05, 0.04±0.05 and 0.09±0.09 logMAR, respectively. Mean SE was -0.17±0.20D (min -0.75D, max +0.25D). The refractive targets for minimonovision for dominant and nondominant eyes were met in 90.54% (67/74, SE -0.10±0.16D) and 56.76% (42/74, SE -0.21±0.20D) of cases, respectively. The percentage of patients who reported glasses independence for distance, intermediate and near vision was 90.54% (67/74), 100% and 72.97% (54/74), respectively. No optical phenomena were observed in 93.23% (69/74) of cases. A high patient satisfaction for daily life activities was reported.

Conclusion

Bilateral implantation of this non-diffractive extended vision IOL in a minimonovison strategy provides excellent uncorrected binocular distance and intermediate visual acuities, and even near visual acuity in photopic conditions. This IOL provides high level of patient satisfaction even for very demanding patients, spectacle independence and minimizes unwanted visual effects.